Benefits of different drug formulations in psychopharmacology
- 1 September 2003
- journal article
- conference paper
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 13, 77-84
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principleEuropean Journal of Pharmaceutics and Biopharmaceutics, 2002
- Timing treatment to the rhythm of diseasePostgraduate Medicine, 2001
- Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patientsDiabetologia, 2001
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- Pulmonary Insulin Administration Using the AERx® System: Physiological and Physicochemical Factors Influencing Insulin Effectiveness in Healthy Fasting SubjectsDiabetes Technology & Therapeutics, 2000
- Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebosJournal of Neurology, 2000
- Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.Health Technology Assessment, 2000
- Phobic Symptoms, Particularly the Fear of Blood and Injury, Are Associated With Poor Glycemic Control in Type I Diabetic AdultsDiabetes Care, 1997
- Translating Safety, Efficacy and Compliance into Economic Value for Controlled Release Dosage FormsPharmacoEconomics, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993